Podcast

Pharmacy Focus Episode 14: The Neurological Impact of COVID-19

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

In this week’s episode, we will be discussing the neurological impacts that COVID-19 has on the brain with Daniel Wilson, president of Western University Health Sciences and former president of the American Neuropsychiatric Association. If you would like to nominate a pharmacist or pharmacy staff member as a Pharmacy Hero, email AAntrim@pharmacytimes.com!

Related Videos
Alzheimer and dementia clock drawing cognitive test -- Image credit: Jovana Milanko/Stocksy | stock.adobe.com
Doctor hands making a vaccination in the shoulder of patient
Trisha Winroth, PharmD, and Ashly McPhillips, PharmD
Caregiver holding elderly man's hand -- Image credit: Chinnapong | stock.adobe.com
Health care worker looking at MRI scans of dementia -- Image credit: Atthapon | stock.adobe.com
Neurons in Alzheimer disease -- Image credit: Dr_Microbe | stock.adobe.com
Amyloid plaques in brain -- Image credit: Dr_Microbe | stock.adobe.com
Elderly man completing puzzle Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Related Content
Myasthenia Gravis disease blood test in doctor hand
October 21st 2024

Myasthenia Gravis Negatively Impacts Patients and Care Partners Through Clinical, Financial Burdens

Luke Halpern, Assistant Editor
Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Woman sitting when cannot walk on stairs and stops then hold her legs for support and rest with feel tingling.
October 18th 2024

Repeat IVIG Dosing Common in Guillain-Barré Syndrome, Suggesting Harm in Non-Responders

Luke Halpern, Assistant Editor
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

COVID-19 vaccine -- Image credit: Daniel Jędzura | stock.adobe.com
October 18th 2024

FDA Places Clinical Hold on Novavax COVID-19/Influenza and Standalone Influenza Vaccine Trials

Gillian McGovern, Assistant Editor
FDA approved oral medication -- Image credit: Anny Art | stock.adobe.com
Published: October 17th 2024 | Updated: October 17th 2024

FDA Approves Sodium Oxybate to Treat Cataplexy or EDS in Pediatric Patients With Narcolepsy

Gillian McGovern, Assistant Editor